Dr David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
DalCor Pharmaceuticals today announced the appointment of Dr. David G. Kallend as Chief Scientific Officer effective July 1, 2020.
Menu
DalCor Pharmaceuticals today announced the appointment of Dr. David G. Kallend as Chief Scientific Officer effective July 1, 2020.
Canada2001 Boulevard Robert Bourassa,
Suite 1700
Montreal, Quebec H3A 2A6
Tel.: +1 514-508-5099
Fax.: +1 514-564-6424
Email: [email protected]
SWITZERLANDBaarerstrasse 2 CH-6302 Zug
Tel.: +41 41 727 67 89
Email: [email protected]
UNITED KINGDOMQ3, the Square Randalls Way
Leatherhead KT22 7TW
Tel: +44 207-842-2275
Email: [email protected]
UNITED STATESYou cannot copy content of this page